{
  "case_id": "Case_5",
  "model_id": "google/gemma-2-9b-it",
  "content": "{\n    \"primary_diagnosis\": {\n        \"name\": \"Parkinson's Disease\",\n        \"confidence\": 0.7,\n        \"icd_code\": \"G20\",\n        \"reasoning\": \"Classic triad of tremor, bradykinesia, and rigidity, with onset after exposure to potential environmental risk factors.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Manganese Toxicity\",\n            \"confidence\": 0.2,\n            \"icd_code\": \"G72.5\",\n            \"reasoning\": \"Possible exposure to manganese during water purification work in Bangladesh, given the similarity of symptoms to Parkinsonism.\"\n        },\n        {\n            \"name\": \"Drug-Induced Parkinsonism\",\n            \"confidence\": 0.05,\n            \"icd_code\": \"Unknown\",\n            \"reasoning\": \"Less likely given no history of medication use that could cause Parkinsonian symptoms, but needs to be ruled out.\"\n        },\n        {\n            \"name\": \"Multiple System Atrophy\",\n            \"confidence\": 0.05,\n            \"icd_code\": \"G20.8\",\n            \"reasoning\": \"Considered due to the subtle signal abnormalities in the basal ganglia, however, the specific symptom presentation leans more towards Parkinson's.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Progressive onset of tremor, bradykinesia, and rigidity\",\n        \"Temporal relationship between symptom onset and return from rural Bangladesh\",\n        \"Subtle basal ganglia abnormalities on MRI\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Lumbar puncture with manganese level analysis\",\n            \"purpose\": \"To rule out manganese toxicity\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Comprehensive medication review\",\n            \"purpose\": \"To identify any potential causative medications\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"DaTscan\",\n            \"purpose\": \"To further assess dopaminergic system function and differentiate from other parkinsonian syndromes\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Initiate supportive care measures\",\n            \"Educate the patient about Parkinson's Disease and potential causes\"\n        ],\n        \"medications\": [],\n        \"monitoring\": [\n            \"Monitor disease progression and symptom severity\",\n            \"Frequency: Monthly\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Neurologist\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"For definitive diagnosis and management\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Rapidly progressing symptoms\",\n        \"Presence of autonomic dysfunction\"\n    ],\n    \"patient_education\": [\n        \"About Parkinson's Disease and its potential causes\",\n        \"Importance of early diagnosis and treatment\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"Within 1 week for neurology consultation\",\n        \"conditions\": \"Any exacerbation of symptoms or development of new neurological signs\"\n    },\n    \"confidence_in_assessment\": 0.7,\n    \"uncertainties\": [\n        \"Exact cause of Parkinsonism (requires further testing)\",\n        \"Potential for other co-morbidities\"\n    ]\n}",
  "latency": 1.8069701194763184,
  "timestamp": "2025-08-10T01:16:51.364128",
  "cached_at": "2025-08-10T01:16:51.364131"
}